azoxymethane has been researched along with nitroaspirin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bak, AW; Calignano, A; Cirino, G; Del Soldato, P; Li, P; McKnight, W; Wallace, JL | 1 |
Kopelovich, L; Liu, X; Ouyang, N; Patlolla, JM; Rao, CV; Reddy, BS; Rigas, B; Simi, B; Steele, VE; Wang, CX | 1 |
2 other study(ies) available for azoxymethane and nitroaspirin
Article | Year |
---|---|
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Aspirin; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Isoenzymes; Male; Membrane Proteins; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1998 |
Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Topics: Acetates; Animals; Antineoplastic Agents; Aspirin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Humans; Indoles; Male; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344 | 2006 |